6708 Federal Register / Vol. 70, No. 25 / Tuesday, February 8, 2005 / Notices 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS)

Dated: February 2, 2005. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 05–2353 Filed 2–7–05; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

National Cancer Institute Director’s 

Consumer Liaison Group. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting.

Name of Committee: National Cancer 

Institute Director’s Consumer Liaison Group. 

Date: February 28–March 1, 2005. 

Time: 8 a.m. to 5 p.m. 

Agenda: 1. Reports from NCI: Health 

Disparities; Planning; Survivorship; 2. Status 

of NCI Listens and Learns Web Site; 3. 

Listens and Learns Evaluation Plan and 

Summit Evaluation Plan; 4. Listens and 

Learns Working Group Meetings; 5. Meetings 

with NCI Deputy Director; 6. Public 

Comment; 7. Next steps. 

Place: Holiday Inn Select Bethesda, 8120 

Wisconsin Ave, Bethesda, MD 20814. 

Contact Person: Nancy Caliman, Executive 

Secretary, Office of Liaison Activities, 

National Institutes of Health, National Cancer 

Institute, 6116 Executive Boulevard, Suite 

220, MSC8324, Bethesda, MD 20892, (301) 

496–0307, calimann@mail.nih.gov. 

This notice is to be published less than 15 

days prior to the meeting due to scheduling 

conflicts. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Information is also available on the 

Institutes’s/Center’s home page: http://

deainfo.nci.nih.gov/advisory/dclg/dclg.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.932, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS)

Dated: February 2, 2005. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 05–2354 Filed 2–7–05; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 10(a) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

National Cancer Institute Board of 

Scientific Advisors. 

The meeting will be open to the 

public, with attendance limited to space 

available. Individuals who plan to 

attend and need special assistance, such 

as sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting.

Name of Committee: National Cancer 

Institute Board of Scientific Advisors. 

Date: March 7–8, 2005. 

Time: March 7, 2005, 8 a.m. to 10:30 a.m. 

Agenda: Joint meeting of the NCI Board of 

Scientific Advisors and NCI Board of 

Scientific Counselors; Report of the Director, 

NCI; Legislative Update; and Ethics 

Overview. 

Place: National Cancer Institute, Building 

31, C Wing, 6 Floor, 9000 Rockville Pike, 

Conference Room 10, Bethesda, MD 20892. 

Time: March 7, 2005, 10:30 a.m. to 6 p.m. 

Agenda: Ongoing and New Business; 

Reports of Program Review Group(s); and 

Budget Presentation; Reports of Special 

Initiatives; RFA and RFP Concept Reviews; 

and Scientific Presentations. 

Place: National Cancer Institute, Building 

31, C Wing, 6 Floor, 9000 Rockville Pike, 

Conference Room 10, Bethesda, MD 20892. 

Time: March 8, 2005, 8:30 a.m. to 1 p.m. 

Agenda: Reports of Special Initiatives; RFA 

and RFP Concept Reviews; and Scientific 

Presentations. 

Place: National Cancer Institute, Building 

31, C Wing, 6 Floor, 9000 Rockville Pike, 

Conference Room 10, Bethesda, MD 20892. 

Contact Person: Paulette S. Gray, PhD, 

Executive Secretary, Acting Director, 

Division of Extramural Activities, National 

Cancer Institute, National Institutes of 

Health, 6116 Executive Boulevard, 8th Floor, 

Rm. 8001, Bethesda, MD 20892, 301–496–

5147. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

into the building by non-government 

employees. Persons without a government 

I.D. will need to show a photo I.D. and signin at the security desk upon entering the 

building. 

Information is also available on the 

Institute’s/Center’s home page: http://

deainfo.nci.nih.gov/advisory/bsa.htm, where 

an agenda and any additional information for 

the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS)

Dated: February 2, 2005. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 05–2355 Filed 2–7–05; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Cancer 

Institute Special Emphasis Panel. TREC 

Coordination Center. 

Date: March 3, 2005.